Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase

<p>Abstract</p> <p>Background</p> <p>HIV-1 nucleoside reverse transcriptase inhibitors (NRTIs) have been used in the clinic for over twenty years. Interestingly, the complete resistance pattern to this class has not been fully elucidated. Novel mutations in RT appearing...

Full description

Bibliographic Details
Main Authors: Kagan Ron M, de Graaf Loek, van Ham Petronella M, Huigen Marleen CDG, Boucher Charles AB, Nijhuis Monique
Format: Article
Language:English
Published: BMC 2008-02-01
Series:Retrovirology
Online Access:http://www.retrovirology.com/content/5/1/20
id doaj-679687ae53314ee4a6595caa89b92efb
record_format Article
spelling doaj-679687ae53314ee4a6595caa89b92efb2020-11-25T02:28:17ZengBMCRetrovirology1742-46902008-02-01512010.1186/1742-4690-5-20Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptaseKagan Ron Mde Graaf Loekvan Ham Petronella MHuigen Marleen CDGBoucher Charles ABNijhuis Monique<p>Abstract</p> <p>Background</p> <p>HIV-1 nucleoside reverse transcriptase inhibitors (NRTIs) have been used in the clinic for over twenty years. Interestingly, the complete resistance pattern to this class has not been fully elucidated. Novel mutations in RT appearing during treatment failure are still being identified. To unravel the role of two of these newly identified changes, E40F and K43E, we investigated their effect on viral drug susceptibility and replicative capacity.</p> <p>Results</p> <p>A large database (Quest Diagnostics database) was analysed to determine the associations of the E40F and K43E changes with known resistance mutations. Both amino acid changes are strongly associated with the well known NRTI-resistance mutations M41L, L210W and T215Y. In addition, a strong positive association between these changes themselves was observed. A panel of recombinant viruses was generated by site-directed mutagenesis and phenotypically analysed. To determine the effect on replication capacity, competition and <it>in vitro </it>evolution experiments were performed. Introduction of E40F results in an increase in Zidovudine resistance ranging from nine to fourteen fold depending on the RT background and at the same time confers a decrease in viral replication capacity. The K43E change does not decrease the susceptibility to Zidovudine but increases viral replication capacity, when combined with E40F, demonstrating a compensatory role for this codon change.</p> <p>Conclusion</p> <p>In conclusion, we have identified a novel resistance (E40F) and compensatory (K43E) change in HIV-1 RT. Further research is indicated to analyse the clinical importance of these changes.</p> http://www.retrovirology.com/content/5/1/20
collection DOAJ
language English
format Article
sources DOAJ
author Kagan Ron M
de Graaf Loek
van Ham Petronella M
Huigen Marleen CDG
Boucher Charles AB
Nijhuis Monique
spellingShingle Kagan Ron M
de Graaf Loek
van Ham Petronella M
Huigen Marleen CDG
Boucher Charles AB
Nijhuis Monique
Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase
Retrovirology
author_facet Kagan Ron M
de Graaf Loek
van Ham Petronella M
Huigen Marleen CDG
Boucher Charles AB
Nijhuis Monique
author_sort Kagan Ron M
title Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase
title_short Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase
title_full Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase
title_fullStr Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase
title_full_unstemmed Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase
title_sort identification of a novel resistance (e40f) and compensatory (k43e) substitution in hiv-1 reverse transcriptase
publisher BMC
series Retrovirology
issn 1742-4690
publishDate 2008-02-01
description <p>Abstract</p> <p>Background</p> <p>HIV-1 nucleoside reverse transcriptase inhibitors (NRTIs) have been used in the clinic for over twenty years. Interestingly, the complete resistance pattern to this class has not been fully elucidated. Novel mutations in RT appearing during treatment failure are still being identified. To unravel the role of two of these newly identified changes, E40F and K43E, we investigated their effect on viral drug susceptibility and replicative capacity.</p> <p>Results</p> <p>A large database (Quest Diagnostics database) was analysed to determine the associations of the E40F and K43E changes with known resistance mutations. Both amino acid changes are strongly associated with the well known NRTI-resistance mutations M41L, L210W and T215Y. In addition, a strong positive association between these changes themselves was observed. A panel of recombinant viruses was generated by site-directed mutagenesis and phenotypically analysed. To determine the effect on replication capacity, competition and <it>in vitro </it>evolution experiments were performed. Introduction of E40F results in an increase in Zidovudine resistance ranging from nine to fourteen fold depending on the RT background and at the same time confers a decrease in viral replication capacity. The K43E change does not decrease the susceptibility to Zidovudine but increases viral replication capacity, when combined with E40F, demonstrating a compensatory role for this codon change.</p> <p>Conclusion</p> <p>In conclusion, we have identified a novel resistance (E40F) and compensatory (K43E) change in HIV-1 RT. Further research is indicated to analyse the clinical importance of these changes.</p>
url http://www.retrovirology.com/content/5/1/20
work_keys_str_mv AT kaganronm identificationofanovelresistancee40fandcompensatoryk43esubstitutioninhiv1reversetranscriptase
AT degraafloek identificationofanovelresistancee40fandcompensatoryk43esubstitutioninhiv1reversetranscriptase
AT vanhampetronellam identificationofanovelresistancee40fandcompensatoryk43esubstitutioninhiv1reversetranscriptase
AT huigenmarleencdg identificationofanovelresistancee40fandcompensatoryk43esubstitutioninhiv1reversetranscriptase
AT bouchercharlesab identificationofanovelresistancee40fandcompensatoryk43esubstitutioninhiv1reversetranscriptase
AT nijhuismonique identificationofanovelresistancee40fandcompensatoryk43esubstitutioninhiv1reversetranscriptase
_version_ 1724839340139347968